Testing for hepatitis B virus alone does not increase vaccine coverage in non-immunized persons

Table 2 Hepatitis B virus vaccination and no reply rates across study centers

	n	No reply n (%)	Immunization coverage
			Vaccinatedn3	Per protocol1(%)	ITT2(%)
Total	1215	313 (25.8)	99	11	8.2
General practitioner	418	85 (20.3)	21	6.3	5
Policlinique Saint Antoine	165	47 (28.5)	10	8.6	6.1
Travel clinic Saint Antoine	31	5 (16.1)	3	11.5	10
CPAM	222	33 (14.9)	8	4.2	3.6
STD clinics	635	166 (26.1)	35	7.5	5.5
CDAG Saint Antoine	51	10 (19.6)	0	0	0
CDAG Figuier	275	78 (28.4)	22	11.2	8
CDAG Belleville	309	78 (25.2)	13	5.6	4.2
Immigrant-health clinics	140	61 (43.6)	37	46.8	26.4
Croix-Rouge Moulin Joly	9	0 (0)	5	55.6	55.6
CRAMIF	18	0 (0)	9	50	50
Médecin du Monde	113	61 (54.0)	23	44.2	20.4
Prison (UCSA Paris)	22	0 (0)	6	27.3	27.3

¹Per-protocol end-point defined as the proportion of non-immunized participants initiating vaccination who were contacted;

²Intent-to-treat (ITT) end-point defined as the proportion of non-immunized participants initiating vaccination assuming that those who were unable to be contacted did not initiate or complete vaccination;

³Participants initiating HBV vaccination sequence after HBV testing in the OPTISCREEN-B study. CDAG: Centre de dépistage anonyme et gratuit; CPAM: Caisse primaire d’assurance maladie; CRAMIF: Caisse régionale d'assurance maladie d'Ile-de-France; UCSA: Unité de consultations et de soins ambulatoire; STD: transmitted disease.